GAM
INSM icon

Groupama Asset Management’s Insmed INSM Stock Holding History

Groupama Asset Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$580K Sell
5,541
-49
-0.9% -$5.93K 0.01% 298
2026
Q1 		$914K Hold
5,590
– – 0.01% 219
2025
Q4 		$973K Sell
5,590
-7,585
-58% -$1.38M 0.01% 255
2025
Q3 		$1.9M Hold
13,175
– – 0.03% 174
2025
Q2 		$1.31M Buy
+13,175
New +$1.01M 0.02% 245
2025
Q1 		– Hold
0
– – – 257
2024
Q4 		– Sell
-579
Closed -$41.7K – 289
2024
Q3 		$773K Buy
+579
New +$42.7K 0.02% 292

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Groupama Asset Management's INSM Position: Q2 2026 in Review

Groupama Asset Management reduced its Insmed (INSM) stake by 0.88% in Q2 2026, selling an estimated $5.93K and leaving 5,541 shares worth $580K. The position accounts for 0.01% of the portfolio, ranked #298.

Groupama Asset Management first reported a position in INSM in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.9M in Q3 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Groupama Asset Management held 5,541 shares of Insmed worth $580K as of Q2 2026.
  • Groupama Asset Management sold 49 Insmed shares in Q2 2026, an estimated $5.93K.
  • Insmed made up 0.01% of Groupama Asset Management's portfolio in Q2 2026, its #298 holding.
  • Groupama Asset Management first reported a position in Insmed in Q3 2024 and has held it in 6 quarters since.
  • Groupama Asset Management's Insmed position peaked at $1.9M in Q3 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.